Glycans are fundamental cellular building blocks, involved in many organismal functions. 25
network. A simple change of a single intermediate glycan or glycosyltransferase will have 48
cascading impacts on the final glycans obtained 5,6 . Unfortunately, glycoprofiling and glycomic 49 data lack the necessary systems perspective to easily decode this potential for change. It is 50 important to understand the network behind the glycoprofiles so that we can better understand 51 the regulation of this process. 52
New tools that aid in the acquisition and aggregation of glycoprofiles are emerging, making 53 large-scale comparisons of glycoprofiles possible. Advances in mass spectrometry now enable 54 the rapid generation of large volumes of glycoprofiles with detailed glycan composition 7-10 , 55 exposing the complex and heterogeneous glycosylation patterns on lipids and proteins 11, 12 . Large 56 glycoprofile datasets and supporting databases are also emerging, including GlyTouCan 13 , 57
UnicarbDB 14 , Glygen and UniCarbKB 15 . 58
These new technologies and databases provide opportunities to examine global trends in 59 glycan function and their association with disease. However, the rapid and accurate comparison 60 of glycoprofiles can be challenging with the size, sparsity and heterogeneity of such datasets. 61
Indeed in any one glycoprofiles, only a few glycans may be detected among the thousands of 62 possible glycans. Thus, even in the same dataset, few glycans, if any, overlap between samples if 63 there is a major perturbation to glycosylation. However, these non-overlapping glycans may only 64 4 differ in their synthesis by as few as one enzymatic step. Thus, it can be difficult to know which 65 glycans to compare. Furthermore, since glycans often share substantion portions of their 66 biosynthetic pathways with each other, statistical methods that assume independence (e.g., t-67 tests, ANOVA, etc) are inappropriate for glycomics. Here we address these challenges by 68
proposing that glycan substructures, or intermediates, are useful functional units to enable 69 meaningful glycoprofile comparisons, since each substructure can capture one step in the 70 complex process of glycan synthesis. Thus, using substructures for comparison, we account for 71 the shared dependencies of all glycans. 72
Previous work has investigated the similarity across glycans using glycan motifs, such as 73 glycan fingerprinting to describe glycan diversity in glycan databases 16 , alignment of glycan 74 structures 17 , identification of glycan epitopes in glycoprofiles 18 , graph-based deconvolution of 75 LC-MS to clarify glycan abundance 19 , or comparison of glycans in glycoprofiles leveraging 76 simple structures 20 . These tools use information on glycan composition or epitopes. However, 77 accounting for the shared biosynthetic steps in the various glycans in glycoprofiles, provides 78 complete biosynthetic context to all glycan epitopes. That context includes connecting all 79 glycans to the enzymes involved in their synthesis, the order of the enzyme reactions, and 80 information on competition for glycan substrates. Thus, a generalized substructure approach can 81 facilitate the study of large numbers of glycoprofiles and connect them to the shared mechanisms 82 involved in making each glycan. 83
Here we present GlyCompare, a method enabling the rapid and scalable analysis and 84 comparison of any number of glycoprofiles while accounting for the biosynthetic similarities of 85 each glycan. This will facilitate the discovery of mechanisms underlying the changes among 86 glycoprofiles. We demonstrate the functionalities and performance of this approach with both 87 5 protein-conjugated and unconjugated glycomics, using recombinant erythropoietin (EPO) N-88 glycosylation and human milk oligosaccharides (HMOs). Specifically, we analyzed sixteen 89 MALDI-TOF glycoprofiles of EPO, where each glycoprofile is of EPO produced in a different 90 glycoengineered CHO cell line 9, 11 . We also analyzed forty-eight HMO glycoprofiles from six 91 mothers 21 . By analyzing these glycoprofiles with GlyCompare, we quantify the abundance of 92 important substructures, cluster the glycoprofiles of mutant cell lines, connect genotypes to 93 unexpected changes in glycoprofiles, and associate a phenotype of interest with substructure 94 abundance and synthesis network dynamics. The analysis of the EPO and HMO datasets 95 demonstrate that our novel framework presents a convenient and automated approach to 96 elucidate novel insights into complex patterns in glycobiology. 97
Results

98
GlyCompare decomposes glycoprofiles to facilitate glycoprofile comparison 99
Glycoprofiles can be decomposed into glycan substructure abundances. The resulting 100 substructure profile has richer information than whole glycans and enables more precise 101 comparison across conditions. However, the comparison does not need all substructures. Glycan 102 biosynthesis involves long pathways with multiple intermediates and much pathway redundancy. 103
Thus, pathways can be collapsed to obtain a subset of substructures while preserving the 104 information of all glycans in the dataset. We call this minimal set of substructures "glyco-105 motifs". The GlyCompare workflow consists of several steps wherein glycoprofiles are 106 annotated and decomposed, glyco-motifs are prioritized, and each glyco-motif is quantified for 107 subsequent condition-specific comparisons (Fig. 1) . The specific workflow is described as 108 follows. 109 6 First, to characterize each glycoprofile by substructures, all relevant substructures are defined 110 and quantified. Thus, a complete set of glycan substructures is obtained for all glycans in all 111 glycoprofiles being analyzed. For each glycoprofile, the abundance of each substructure is 112 calculated by summing the abundance of all glycans associated with the substructure. This 113 results in a substructure profile, which stores abundances for all glycan substructures ( Fig. 1a,b ) 114 in given glycoprofile. 115
Second, to identify the most informative substructures (glyco-motifs), substructures are 116 prioritized using the substructure network. The substructure network is built by connecting all 117 substructures into their biosynthetic pathways ( Fig. 1c) . To improve computational efficiency, 118 only substructures associated with glycans being analyzed are included in the substructure 119 network. Starting from the monosaccharides, each level of the network represents another 120 biosynthetic step, with one more monosaccharide than the previous level. The edges in the 121 network are the enzymatic reactions adding each monosaccharide. These edges are weighted by 122 the correlation between the abundances of the substrate and product substructures across all 123 samples. Redundant substructures can be easily identified since their parent-child substructure 124 abundances will be perfectly correlated. Substructure network reduction proceeds by collapsing 125 links with a perfect correlation between substrate and product substructures, and only retaining 126 the product substructure. The remaining substructures are termed glyco-motifs; they completely 127 describe the variance at the substructure level. The abundances of all glyco-motifs are then 128 represented with a glyco-motif profile, the minimal subset of meaningful substructure 129 abundances ( Fig. 1d) . 130
For larger datasets, summarizing the glyco-motifs becomes necessary. Since the glyco-motifs 131 are also clustered when clustering the glycoprofiles (Fig. 1d) , representative substructures are 132 7 generated by summarizing the common structure in each cluster (Fig. 1e) . The representative 133 substructure describes the glycan features that vary the most across samples. To extract the 134 common structure features, the average weight of each monosaccharide is calculated and the 135 monosaccharides with a weight larger than 51% are preserved, which illustrates the predominant 136 structure in the cluster. This allows one to quickly evaluate the distinguishing glycan features 137 that vary across samples in any given dataset. 138
The workflow we described here successfully connects all glycoprofiles in a data set by their 139 shared intermediate substructures, thus allowing robust analysis of the differences across 140 glycomics samples and the evaluation of the associated genetic bases. 141 142
GlyCompare accurately clusters glycoengineered EPO samples 143
In examining the EPO glycosylation data 9 , we found the glycoprofiles failed to form robust 144 clusters that can be easily interpreted. Furthermore, glycoprofiles with low genetic similarity 145 clustered together ( Fig. 2a and Supplementary Fig. 1,2) . This inconsistency and poor 146 clustering stems from the inherent sparseness of the glycoprofile datatype, i.e., each glycoprofile 147 only has a few glycans, making the matrix of all samples very sparse, unfit for standard 148 clustering approaches, and thus hard to interpret. Particularly problematic is that pairs of glycans 149 differing in a single monosaccharide are treated as two completely different glycans under 150 standard clustering approaches. Thus, we found that clustering is affected more by the presence 151 or absence of a glycan, rather than structural similarity. 152
GlyCompare addresses these problems by elucidating hidden similarities between glycans 153 after decomposing glycoprofiles to their composite substructures. The 52 glycans were 154 decomposed into their constituent glycan substructures, resulting in a substructure profile that 155 8 consists of 613 glycan substructures and a further simplified 120 glyco-motif profile 156 ( Supplementary Fig. 3) . The clustering automatically distinguished the samples based on the 157 structural patterns, and clustered the glyco-motif profiles into groups more consistently 158 associated with the extent of changes in the profile than the raw glycan-based clusters ( Fig. 2b  159 and Supplementary Fig. 4, 5) . 160
The sixteen glycoprofiles clustered into three groups with a few outliers (Fig. 2b) , and the 120 161 glyco-motifs clustered into twenty-four groups, each summarized by representative substructures 162 ( Fig. 2c and Supplementary Fig. 5 ). The clusters of glycoprofiles are consistent with the 163 genetic similarities among the host cells. Specifically, the major substructure patterns cluster 164 individual samples into groups of 'wild-type (WT)-like', 'mild', 'medium' and 'outlier' 165 categories. The WT-like category contains one group, WT and B4galt1/2/3/4/ knockouts, which 166 contains most of the substructures seen in WT cells. The mild group includes the Mgat4b/4a, 167
Mgat4b, and Mgat5 knockouts, which each lose the tetra-antennary structure, and an individual 168 St3gal4/6 knockout that loses the terminal sialylation. The medium category is a group that 169 contains knockouts of St3gal4/6 and Mgat4a/4b/5, knockouts of Mgat4a/4b/5 and B3gnt2, 170 knockouts of Mgat4a/4a/5 with a knock-in of human ST6GAL1, and knockouts of Mgat4a/4b/5 171 and St3gal4/6, which lose the tri-antennary structure. The 'outlier' category includes three 172 individual glycoprofiles with knockouts for Fut8, Mgat2, and Mgat1, each of which generate 173 many glycans not detected in the WT nor other three groups ('WT-like', 'mild' and 'medium'). 174
While some glyco-motif clusters can be seen in the glycoprofile clusters, there are important 175 differences, and the glyco-motif clusters provide more information and improved cluster stability 176 ( Supplementary Fig. 2) . The results demonstrated the excellent performance of our 177
GlyCompare in assessing the structural similarity between different glycoprofiles. 178
GlyCompare identifies substructure changes across glycoprofiles 180
GlyCompare helps to more robustly group samples by accounting for the biosynthetic and 181 structural similarities of glycans. Further analysis of the representative structures provides 182 detailed insights into which structural features vary the most across samples. To accomplish this, 183
we standardized--using z-score normalization--the representative structure abundances. We then 184 identified significant changes in representative substructure abundances between mutant cells 185 and WT (Fig. 2d) . This highlights the specific structural features of glycans that are impacted 186 when glycoengineering recombinant EPO. 187 As expected, in the Mgat1 knockout glycoprofile, only high mannose N-glycans are seen. 188
Also, in the Mgat2 knockout, the glycan substructure of bi-antennary on one mannose linkage 189 significantly increases, and the unique structure of bi-antennary LacNac elongated in the N-190 glycans emerges in the St3gal4/6 and Mgat4a/4b/5 knockouts. Along with expected changes in 191 α-1,6 fucosylation in the Fut8 knockout glycoprofile, we also observed an increase in the tetra-192 antennary poly-LacNac elongated N-glycan without fucose, which has not been previously 193 reported ( Fig. 3a) . In the St3gal4/6 knockout ( Fig. 3a) , we observed the relative abundance of 194 structures with sialylation has significantly decreased, where the tetra-antennary and triantennary 195 poly-LacNAc elongated N-glycan substructure without sialylation significantly increased 196 (Rep13: p<0.01, Rep20: p<0.001). Finally, in the Mgat4b, Mgat4a/4b and Mgat5 knockout 197 glycoprofiles ( Fig. 3b) , tetra-antennary substructures (Rep16-Rep22) decreased significantly 198 Many secreted and measured glycans are also precursors, or substructures, of larger glycans ( Fig.  210   4a) . Thus, the secreted and observed abundance of one glycan does not equal to the total amount 211 synthesized. GlyCompare can quantify the total abundance of a glycan by combining the glycan 212 abundance with the abundance of its products. To demonstrate this capability of GlyCompare, 213 we analyzed HMO abundance, and examined the impact of secretor status and days postpartum 214 on HMO abundance. We obtained forty-seven HMO glycoprofiles from 6 mothers (1, 2, 3, 4, 7, 215 14, 28 and 42 days postpartum (DPP)), 4 "secretor" mothers with functioning FUT2 (α-1,2 216 fucosyltransferase), and 2 "non-secretor" mothers with non-functional FUT2. With the non-217 independence of HMOs addressed with GlyCompare, we were able to use powerful statistical 218 methods to study trends in HMO synthesis. Specifically, we used Generalized Estimating 219 Equations 22 to build regression models predicting secretor status and DPP from substructure 220 abundance. 221
We first checked both the glycan-level and substructure-level clustering of the glycoprofile. 222
Samples with same secretor status and days postpartum (DPP) were successfully grouped 223 ( Supplementary Fig. 6 ). Further examination of the total amount of substructure synthesized 224 11 revealed phenotype-related trends invisible at the level of the raw glycoprofile. For example, the 225 LSTb substructure (X80) increased in secretor mothers (Wald p = 0.001) and decreased in non-226 secretor mothers over time (Wald p < 2.2x10 -16 ; Fig. 4b ). Yet, the same trend was weak or 227 inconsistent for all glycans containing the X80 substructure: LSTb, DSLNT and DSLNH. Like 228 X80, LSTb and DSLNT decreased in abundance over time in non-secretors (LSTb Wald 229 p=0.0046, DSLNT Wald p = 0.0045); however, unlike X80, neither LSTb nor DSLNT 230 significantly increased in secretor mothers over time (Wald p>0.15 ). Meanwhile, DSLNH, like 231 X80, increased over time in secretor mothers (Wald p=0.0062) ( Fig. 4e) . Rather than decreasing 232 like X80, non-secretor DSLNT abundance significantly increased over time (Wald p=5.8x10 -9 ) 233 ( Fig. 4d) . The secretor-specific trends in total LSTb are only visible examining the X80 234 substructure abundance (Fig. 4c) . Thus, while secretor status is expected to impact HMO 235 fucosylation, GlyCompare reveals associations with non-fucosylated substructures. Viewing 236 substructure abundance as total substructure synthesized provides a new fundamental measure to 237 the study of glycoprofiles, it also creates an opportunity to explore trends in synthesis. 238 239
GlyCompare identifies condition-specific synthesis dynamics 240
We applied GlyCompare to explore changes in HMO synthesis over time. We estimate the fluxes 241 for each biosynthetic reaction by quantifying the ratio of product-reactant pairs (pairs of glycan 242 substructures that differ by one monosaccharide). By comparing the substructure abundance of 243 reactants and products, we can estimate how many reactant substructures are converted to 244 product substructure. With clearly defined glycan biosynthesis pathways, we explore synthesis 245 dynamics through the systematic estimation of reaction flux under various conditions. 246 12 We measured the product/reactant ratio for every reaction in the HMO substructure network 247 ( Supplementary Fig. 7) to estimate flux for each reaction over time and across secretor status. 248
We found several reactions strongly associated with secretor status ( Supplementary Table 1  249 and Supplementary Fig. 8) , i.e. the ability of the mother to add an α-1,2 fucose to HMOs. As 250 expected, the reaction flux from the LNT substructure (X38) to the LNFPI substructure (X86), 251 was strongly associated with secretor status (Wald p<2.2x10 -16 ) (Fig. 4a) . In secretors, 36.2% of 252 X38 was converted to X86, compared to non-secretors, wherein only 5% of X38 was converted. 253
Eventhough secretor status is defined by the fucosyltransferase-2 genotype, not all secretor-254 associated reactions were fucosylation reactions. We further explored the secretor-X80 255 association using the product/reactant ratio. Specifically, we examined the upstream reaction of 256 LNT (X38) to LSTb (X80) and the downstream reaction--LSTb (X80) to DSLNT (X103) ( Fig.  257   4b, 5a ). Using the product/reaction ratio of substructure abundances, we found secretor status 258 correlates with the reaction of LSTb to DSLNT but does not impact the conversion of LNT to 259 LSTb; any changes in sialylation is intriguing considering secretor status only directly impacts 260 fucosylation. We measured the upstream reaction of LNT converting to LSTb, using the 261 X80/X38 ratio over time; however, no significant change was observed with respect to secretor 262 status (Wald p=0.44). In the reaction of LSTb to DSLNT, we found a secretor-specific reaction 263
propensity. Specifically, we quantified the association of the X103/X80 ratio with secretor status. 264
The X103/X80 ratio was significantly higher (Wald p=0.018) in secretor mothers (Fig. 5b) . The 265 higher ratio suggests that the turnover from LSTb (X80) to DSLNT (X103) is significantly 266 higher in secretor mothers. In the average non-secretor mother, 52.3% of LSTb is converted to 267 DSLNT. Meanwhile in secretors, the average conversion rate is 81.8% (a 63.9% reduction in the 268 efficiency of the LSTb to DSLNT conversion). The LSTb to DSLNT conversion rate appears 269 13 higher in secretors while conversion from the LSTb precursor, LNT, appears unchanged. 270
Examining the product/reactant ratio has revealed a phenotype-specific reaction propensity thus 271 providing insight to the condition-specific synthesis. 272
273
Discussion
274
Glycosylation has generally been studied from the whole-glycan perspective using mass 275 spectrometry and other analytical methods. From this perspective, two glycans that differ by only 276 one monosaccharide are completely distinct and are not comparable. Thus, the comparative study 277 of glycoprofiles has been limited to changes between glycans shared by multiple glycoprofiles or 278 small manually curated glycan substructures 16 . Glycompare sheds light on the hidden 279 biosynthetic interdependencies between glycans by integrating the biosynthetic pathways into the 280 comparison. Glycoprofiles are converted to glyco-motif profiles, wherein each substructure 281 abundance represents the cumulative abundance of all glycans containing that substructure. This 282 enumeration and quantification of substructures can be easily scaled up to include many 283 glycoprofiles in large datasets. Additionally, since no prior information is required beyond 284 glycan identities and quantities, the method can even facilitate analysis of glycans with limited 285 characterization. Thus, it brings several advantages and new perspectives to enable the 286 systematic study of glycobiology. 287
First, the GlyCompare platform computes a glyco-motif profile (i.e., the abundances of the 288 minimal set of glycan substructures) that maintains the information of the original glycoprofiles, 289 while exposing the shared intermediates of measured glycans. These sample-specific glyco-motif 290 profiles more accurately quantify similarities across glycoprofiles. This is made possible since 291 14 glycans that share substructures also share many biosynthetic steps. If the glycan biosynthetic 292 network is perturbed, all glycans synthesized will be impacted and the nearest substructures will 293 directly highlight where the change occurred. For example, in EPO glycoprofiles studied here, 294 the tetra-antennary structure is depleted on the Mgat4A/4B/5 knockout group and the 295 downstream sialylated substructure depleted when St3gal4/6 were knocked out. Such structural 296 patterns emerge in GlyCompare since the tool exposes the substructures through clustering, thus 297 identifying common features in glycans measured across diverse samples. 298
Second, new trends in synthesis network dynamics become visible at the substructure level. 299
For example, in the HMO data set, multiple HMOs are made through a series of steps from LNT 300 to DSLNH (Fig. 4a) . Only when the substructure abundances are computed are we able to 301 observe the secretor-dependent differences in the LSTb substructure, X80. This is particularly 302 interesting since secretor status is defined by changes in α-1,2 fucosylation, but we see here 303 additional secretor-dependent changes to sialylated structures with no fucose. These are the 304 systemic effects invisible without a systems-level perspective due to the interconnected nature of 305 glycan synthesis; this disparity underlines the power of this method. 306
Third, the sparse nature of glycobiology datasets and the inherent connections between 307 glycans make glycomic data unfit for many statistical analyses commonly used. However, the 308 translation of glycoprofiles into substructure abundance provides a framework for more powerful 309 and statistically rigorous analysis of glycomic datasets. Single sample perturbations, such as the 310 knockouts in the glycoengineered EPO, can be compared to wild-type; all substructure data can 311 be normalized and then rigorously distinguished from the control using a one sample t-test. 312
Conditions or phenotypes with many samples, such as the secretor status in the HMO dataset, 313
can be compared using regression models, like Generalized Estimating Equations (GEE) 22 , to 314 15 evaluate the association between the phenotypes and glycosylation. For example, in HMO data, 315 the GEE revealed that the α-1,2 fucose substructure is enriched in secretor status, consistent with 316 the previous studies [23] [24] [25] . Additionally, the GEE discovered that the sialylation increases over 317 time in secretor mothers while decreasing in non-secretor. Finally, in combination with the 318 substructure network, we can systematically study glycan synthesis. The product/reactant ratio 319 provides a regular measure indicating the flux through the glycan biosynthetic pathways. Using 320 the HMO dataset, we demonstrate the power of this perspective by showing that more LSTb is 321 converted to DSLNT in the secretor mother using regression modeling. The perspectives made 322 available through GlyCompare are not limited to t-tests and regression models. 
Glycoprofile preprocess procedures 335
There are three procedures required for preprocessing the studied glycoprofiles (Fig. 1a) . First, 336 glycoprofiles are parsed into glycans with abundance. In each glycoprofile, the glycans are 337 manually drawn and exported with GlycoCT format using the Glytoucan Graphic Input tool 13 . 338
The structure of glycan in GlycoCT format will be further loaded into python using "glypy" (a 339 glycan analysis and glycoinformatics library for Python) for programmatic manipulation. 340
Assuming we have a glycoprofile i, the corresponding abundance of each glycan j in glycoprofile 341 i is represented by . For example, the relative m/z peak in the mass spectrum or the abundance 342 value in an HPLC trace, will be rectified by the total abundances of glycans in this glycoprofile 343 / * . Sometime, the glycans with ambiguous topology will be handled by assuming it could 344 belong to every possible structure with the same probability, thereby creating all possible n 345 structures but with / * abundance of each. Second, glycans are annotated with glycan 346 substructure information and this information is transformed into the glycoprofile vector. The 347 substructures within a glycan are exhaustively extracted by breaking down each linkage or a 348 combination of linkages of the studied glycan. Note that this method cannot currently deal with 349 glycans with ring topology. All substructures extracted will be merged into a substructure set S, 350 in which the complexity degrees are sorted and the duplicated substructures are removed. Then, 351 each glycan will match to the substructure set S resulting in a binary glycan substructure 352 presence (1) or absence (0) ( 1 , . . . , ). Third, a substructure network is built based on the glycoprofile vectors. The 355 substructure network is a directed acyclic graph and each node denotes a glycan substructure. 356
Given the substructure set S, the root node starts from the monosaccharides or a defined root 357 core structure, and a child node is a substructure that has only one monosaccharide added to its 358 parent node. We note that one child node might have multiple parent nodes and vice versa. The 359 child node depends on its parent node(s) since it cannot exist alone without any parent node. 360
361
Generating the glyco-motif vector bases on the substructure abundance 362 A larger subset of the substructure network is necessary to uniquely describe a more diverse set 363 of glycoprofiles while fewer substructures are needed to sufficiently describe more similar 364 glycoprofiles. Comparisons become more focused when only examining these variable 365 substructures. By checking the substructure network, the substructures that have exactly the same 366 abundance can be merged without any information loss. In other words, after the substructure 367 network is generated, it is simplified by merging the substructure nodes. The merging criteria are 368 based on how child substructure node depends on the parent substructure node . The 369 dependency is the correlation of their abundance across all glycoprofiles, ( * , * ). If the 370 correlation is 1, we can conclude that the addition of the specific monosaccharide is not 371 perturbed across all glycoprofiles, which means they carry exactly the same information. Thus, 372 the parent node can be pruned without information loss. All remaining nodes, namely, the glyco-373 motifs, are used to cluster the glycoprofiles. 374
Meanwhile, the weight of each node is initialized at a value of 1. When a node is removed, the 375 weight is equally divided and distributed to child nodes whose correlation with the removed node 376 is 1. Since this method happens from the root to leaves, the node that serves as checkpoint will 377 gain more weight. The weights W are used later for generating the representative substructures. The preprocessed glycoprofiles (see details in the "glycoprofile preprocess procedures") generate 381 the glycoprofile vectors to enable further clustering analysis. Here we used the Pearson 382 correlation and 'complete' distance to cluster the glycoprofiles. This procedure clusters the 383 glycoprofiles and substructures. 384
To identify the representative glycan substructures, a set of glycan substructures with weights 385 W are first aligned. Then, we calculate the sum of monosaccharide weights for each glycan 386 substructure. The representative substructure is thus defined as the glycan substructures with 387 their summed monosaccharide weights greater than 51% of the total weight of glycan 388 substructures. Lastly, the averaged abundances of the representative substructures are generated 389 to assess their differential expressions between different glycoprofiles. 390 391 Specification for HMO data 392 48 milk samples were collected from 6 human mothers (1, 2, 3, 4, 7, 14, 28 and 42 days 393 postpartum (DPP)). HPLC was used to measure the abundances of the 16 major glycans. The 394 relative abundance of each glycan in each milk sample is normalized by / * for the given 395 sample. Then, we followed the substructure network was built as the procedure mentioned 396 above. 397
398
Testing the substructure-phenotype association 399
The General Equation Estimating (GEE from R::geepack 26,27 ) with an exchangeable correlation 400 structure was used to measure associations between motif abundance, secretor status and DPP; 401 these regression models were trained to predict motif abundance from either secretor status or 402 DPP. A Wald Test was used to measure the significance of phenotype contribution. 403 19 404
Product/Reactant Ratio as a proxy for flux and estimating flux-phenotype associations 405
To further isolate motif-specific effects from biosynthetic biases, we explored methods to control 406 for the reactant-product relations. First, we isolated the relative abundance of motifs separated by 407 only one monosaccharide in the biosynthetic network; these are reactant-product relations like 408 LNT and LSTb. Motif abundance represents the total substructure synthesized therefore when 409 we examine the ratio of product/reactant we measure the total amount of the reactant 410 substructure converted to the product substructure in the sample. The Product/Reactant Ratio is 411 therefore a proxy for flux. Using the same GEE repression modeling approach from testing 412 substructure-phenotype associations, we can measure the association between flux between two 413 glycans and a phenotype of interest. Changes in branching are presented for the Mgat4A/4B/5 knockouts. The tetra-antennary 536 substructures (Rep16-Rep22) decreased considerably. The triantennary substructures with 537 elongated GlcNac (Rep13-Rep14) increase significantly (p-value < 0.01). However, the 538 elongated triantennary structure (Rep15) decreases significantly for the Mgat5 and Mgat4B 539 knockouts (p-value < 0.001). In the CHO dataset, the glycan substructure generated by 540
Mgat4A/4B and Mgat5 will be considered as the same topologically. 
